1985
DOI: 10.1001/archopht.1985.01050110037019
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Should Corneal Transplant Donors Be Screened for Human T-Cell Lymphotropic Virus Type III Antibody?

Search citation statements

Order By: Relevance

Paper Sections

Select...
5
1
0
0

Citation Types

0
2
0
0

Year Published

Range
1986
1986
2010
2010

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations

Cited by 6 publications

(2 citation statements)
references

References 6 publications

0
2
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…The main drawback of this examination, when required postmortem, is the difficulty of obtaining blood [3], a prob lem which can only be overcome of the proce dure is adopted during autopsy or cardiac puncture is used. The vitreous cavity, however, can easily be reached and is supposed by the authors to remain unaltered for a 12-hour peri od following death as far as its biochemical structure is concerned [4].…”
Section: Introduction
mentioning
confidence: 44%
“…Another advantage of this technique is that, despite the rich vascular coat involving the eye [4], the material can be collected without having contact with blood or causing any structural damage that may prevent its future use for donation of the cornea or the sclera.…”
Section: Introduction
mentioning
confidence: 48%
See 1 more Smart Citation